Erythromycin Ethylsuccinate
NDC 60219-1504, Erythromycin, suspension, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 60219-1504
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60219-1504-2 | 60219150402 | 100 mL in 1 BOTTLE (60219-1504-2) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/581d7430-1a80-42a6-befb-4c3ae8140392NADAC price for package 60219150402
GET /v1/drugs/nadac/60219150402
Use it
Look up 60219-1504 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60219-1504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.